期刊文献+

重型肝炎并发肝性脑病的影响因素研究 被引量:5

Influential Factors for Severe Hepatitis with Hepatic Encephalopathy
下载PDF
导出
摘要 目的分析重型肝炎并发肝性脑病(HE)的发病率,研究重型肝炎伴HE患者与单纯重症肝炎患者的临床资料和血液生化指标,探讨重型肝炎并发HE的影响因素。方法回顾性分析广西医科大学第八附属医院2008年6月-2011年6月因重型肝炎住院的145例患者。根据患者住院期间是否发生HE,将研究对象分成重型肝炎伴HE(HE组,52例)和单纯重型肝炎组(非HE组,93例)。比较两组患者的肝肾综合征等其他并发症患病率和血液生化指标,并运用非条件Logistic回归模型进行多因素分析。结果重型肝炎并发HE的患病率为35.9%(52/145)。多因素Logistic回归结果显示,进入回归方程的主要因素为:国际标准化比值(INR)(OR=1.57,95%CI:1.04~2.44)、血氨(OR=1.03,95%CI:1.02~1.04)。结论重型肝炎并发HE的患病率较高,国际标准化比值和血氨是影响重型肝炎并发HE的主要危险因素。 Objective To investigate the prevalence rate of hepatic encephalopathy (HE) among severe hepatitis patients, discuss the related influential factors. Methods Total 145 patients with severe hepatitis were enrolled in this study. 52 patients with HE were assigned into HE group and 93 patients without HE into control group. The laboratory indicator, prevalence rate of hepatorenal syndrome and other complications were compared between the two groups. Multivariate analysis was explored by un- conditional logistic regression. Results The prevalence rate of HE among severe hepatitis patients was 35.9% (52/145). Logis- tic regression showed that the international normalized ratio(INR) ( OR = 1.57,95% CI: 1.04 - 2.44), ammonia( OR = 1.03, 95% CI:I. 02 -1.04) were the risk factors of HE in patients with severe hepatitis. Conclusion The prevalence rate of HE a- mong severe hepatitis patients was high. The international normalized ratio(INR) and blood ammonia were the risk factors of HE in patients with severe hepatitis.
出处 《中华全科医学》 2012年第12期1847-1849,共3页 Chinese Journal of General Practice
关键词 重型肝炎 肝性脑病 影响因素 LOGISTIC回归分析 Severe hepatitis Hepatic encephalopathy Influencing factors Logistic analysis
  • 相关文献

参考文献10

二级参考文献52

  • 1李琴,贾继东,王宝恩.凝血酶原时间及凝血因子在肝病中的应用[J].中华肝脏病杂志,2004,12(12):767-768. 被引量:101
  • 2张松涛.凝血因子V检测对慢性重症肝炎诊断的意义[J].临床输血与检验,2005,7(2):120-121. 被引量:2
  • 3段钟平.重型肝炎肝衰竭临床治疗进展[J].中国实用内科杂志,2005,25(9):784-786. 被引量:29
  • 4李兰娟.人工肝临床应用若干进展[J].中华肝脏病杂志,2005,13(11):844-845. 被引量:44
  • 5Yuen MF, Sablon E, Hui CK, et al. Prognostic factors in severe exacerbation of chronic hepatitis B. Clin lnfee Dis, 2003, 36: 979-984.
  • 6Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end stage liver disease. Flepatology, 2001, 33: 464-470.
  • 7Reverter JC. Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? Yes. J Thromb Haemost, 2006, 4: 717-720.
  • 8Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicling prognosis in patients with liver cirrhosis and is correlaled with residual liver function: a European study. Gut, 2003, 52: 134-139.
  • 9Trotter JF, Brimhall B, Arjal R, et al. Specific laboratory meth-odologies achieve higher model for end stage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transpl, 2004, 10, 995-1000.
  • 10Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis.International Ascites Club. Hepatology, 1996, 23: 164-176.

共引文献78

同被引文献40

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部